Legal Opinion from Allbright Law Offices (Wuhan) on Qianjiang Yong'an Pharmaceutical Co., Ltd. 2025 Annual Shareholders' Meeting
Address: 8th Floor, Minsheng Financial Center, 187 Yunxia Road, Jianghan District, Wuhan
Phone: 027-83828888
Postal Code: 430030
Legal Opinion
To: Qianjiang Yong'an Pharmaceutical Co., Ltd.
Allbright Law Offices (Wuhan) (hereinafter referred to as "this firm") has been entrusted by Qianjiang Yong'an Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") to send a lawyer to attend the Company's 2025 Annual Shareholders' Meeting (hereinafter referred to as "this meeting") and to issue this legal opinion regarding the convening of this meeting in accordance with the Company Law of the People's Republic of China (hereinafter referred to as "the Company Law"), the Rules for Shareholders' Meetings of Listed Companies, and other relevant laws, regulations, rules, and normative documents, as well as the Articles of Association of Qianjiang Yong'an Pharmaceutical Co., Ltd. (hereinafter referred to as "the Articles of Association").
In issuing this legal opinion, this firm and its lawyers have strictly fulfilled their statutory duties in accordance with the Administrative Measures for Law Firms Engaging in Securities Legal Business and the Practice Rules for Securities Legal Business of Law Firms (Trial), adhering to the principles of diligence and good faith. Necessary verifications and checks regarding the matters involved in this meeting have been conducted, and relevant documents and materials deemed necessary for issuing this legal opinion have been reviewed. This firm participated in the entire process of the Company's meeting.
This firm guarantees that the facts recognized in this legal opinion are true, accurate, and complete, and that the conclusions drawn are legal and accurate, with no false records, misleading statements, or significant omissions, and is willing to bear corresponding legal responsibilities. This firm agrees to announce this legal opinion together with the resolutions of this meeting and to bear corresponding legal responsibilities for the opinions expressed.
In this regard, the lawyers of this firm, based on the requirements of the aforementioned laws, regulations, rules, and normative documents, and in accordance with the recognized business standards, ethical norms, and spirit of diligence and good faith in the legal profession, hereby issue the following legal opinions:
I. Qualification of the Meeting Convener and Procedures for Convening and Holding the Meeting
- Qualification of the Meeting Convener
After verification, this meeting was convened by the Company's board of directors. On April 29, 2026, the 15th meeting of the 7th board of directors resolved to convene this meeting. The Company issued a notice regarding the convening of the 2025 Annual Shareholders' Meeting on April 30, 2026, through the designated information disclosure media of the China Securities Regulatory Commission, the Giant Tide Information Network (http://www.cninfo.com.cn). The notice specified the convener, date and time of the meeting (including the date and time of the on-site meeting and the date and time for online voting), method of convening, equity registration date, attendees, meeting location, matters for deliberation, registration method for the on-site meeting, specific procedures for participating in online voting, and contact information. The date of the announcement was more than 20 days prior to the date of this meeting.